Status:

COMPLETED

Mindfulness Meditation in Bone Marrow Transplantation

Lead Sponsor:

Emory University

Collaborating Sponsors:

Dana-Farber Cancer Institute

University of Massachusetts, Worcester

Conditions:

Hematologic Malignancy

Bone Marrow Transplantation

Eligibility:

All Genders

21+ years

Phase:

PHASE2

PHASE3

Brief Summary

The main purpose of this study is to examine techniques to help patients cope better with the stem cell/bone marrow transplant procedure.

Detailed Description

Patients will be assigned to one of three study groups: 1. receives the normal standard care; 2. meets with an oncology nurse educator, in addition to the regular nurses on the transplant team. The n...

Eligibility Criteria

Inclusion

  • Autologous stem cell transplantation for hematologic malignancy
  • First transplant
  • 21 years of age or older
  • Speaks and understands English

Exclusion

  • Planned tandem (more than one) transplant
  • Taking corticosteroids on a regular basis for a chronic condition
  • Prior formal mindfulness meditation training
  • Significant cognitive impairment and/or confirmed psychosis or thought disorder

Key Trial Info

Start Date :

April 1 2005

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

June 1 2011

Estimated Enrollment :

241 Patients enrolled

Trial Details

Trial ID

NCT00165282

Start Date

April 1 2005

End Date

June 1 2011

Last Update

November 28 2013

Active Locations (3)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (3 locations)

1

Emory University

Atlanta, Georgia, United States

2

Dana-Farber Cancer Institute

Boston, Massachusetts, United States, 02115

3

University of Massachusetts Medical School

Worcester, Massachusetts, United States, 01655